Beijing Leadman Biochemistry Co.,Ltd.

The company was founded in November 1997 and successfully listed on the Shenzhen Stock Exchange GEM on February 16, 2012. The company is headquartered in the Beijing Economic and Technological Development Zone, has an R&D center and reference laboratory that has reached international advanced standards, and has successfully passed the quality system assessment of the Beijing Drug Administration. The company is a national high-tech enterprise with core competitiveness in the fields of in vitro diagnostic reagents, diagnostic instruments, biochemical raw materials, etc., integrating R&D, production and sales. The company's main products cover biochemical, immunological and other in vitro diagnostic reagents, diagnostic instruments and biochemical raw materials. In vitro diagnostic reagent products include biochemical and immunological diagnostic reagent products; self-produced diagnostic instruments are fully automatic chemiluminescence immunoanalyzers; products in the field of biochemical raw materials include biological enzymes, coenzymes, antigens, antibodies, fine chemicals, etc. The company's honors include: winning the “2017 China Listed Company's Most Socially Responsible Award” in the 2017 Financial Industry Listed Company Value Award; winning the 2016 Four New Enterprise Innovation Award in Shanghai's Pudong New Area; winning the 2016 “Safety Star” award from the Beijing Economic and Technological Development Zone; and winning the honorary title of “Shuxiang Enterprise” in the Beijing Economic and Technological Development Zone in 2023.